This is just the beginning! Our collection holds over 300 years of history, including rare newspapers, obituaries, marriage records, birth records, and so much more—most of which you won’t find anywhere else!
Prospects brighten for smoother drug regulation
Washington watchers say regulatory scrutiny and Reagan era pressure signal a faster, cheaper drug development path and an end to the drug lag. FDA plans streamlined approval, with Schweiker Hayes and industry allies pushing for looser early testing rules, foreign study weight, and advisory-committee power.
MENTIONED IN THIS ARTICLE
Scott Kraft
Associated Press
Washington
U.S
Reagan Administration
William Wardell
Center For the Study of Drug Development
University of Rochester
New York
FDA
Food and Drug Administration
Health and Human Services
Richard Schweiker
Schweiker
Arthur Hull Hayes Jr
Hayes
Congressional
George Bush
Eli Lilly and Co
Gerald Ford
Donald Rumsfeld
G.D. Searle & Co
Senate Health
Kennedy
Senate
House
James Scheuer
D-N.y
Scheuer
Bush
Jim Miller